Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
2-(3,4-Dimethylphenyl)-2,4-dihydro-5-methyl-3H-pyrazol-3-one-13C4 is an intermediate in the synthesis of Eltrombopag-13C4 (E508002), which is an agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia.